MEHP

  Cat. No.:  DC72892   Featured
Chemical Structure
4376-20-9
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
MEHP (Phthalic acid mono-2-ethylexyl ester) is a competitive inhibitor of CYP2C9 with IC50 of 6.37 μM.
Cas No.: 4376-20-9
Chemical Name: 2-(((2-Ethylhexyl)oxy)carbonyl)benzoic acid
Synonyms: 2-(((2-Ethylhexyl)oxy)carbonyl)benzoic acid;Mono-2-ethylhexyl Phthalate;1,2-Benzenedicarboxylic acid, 1-(2-ethylhexyl) ester;2-(2-ethylhexoxycarbonyl)benzoic acid;Monoethylhexyl phthalate (mEHP);rac Mono(ethylhexyl) Phthalate;RAC MONO(ETHYLHEXYL) PHTHALATE,COLORLESS OIL;2-ethylhexyl hydrogen phthalate;Mehp;Mono(2-ethylhexyl) phthalate;PHTHALIC ACID MONO-2-ETHYLHEXYL ESTER;Mono(2-ethylhexyl)phthalate;Monoethylhexyl phthalate;Mono-(2-ethylhexyl)phthalate;(2-Ethylhexyl) hydrogen phthalate;BAR 1;1,2-Benzenedicarboxylic acid, mono(2-ethylhexyl) ester;Phthalate, mono(2-ethylhexyl);Monoethylhexyl phthalic acid;Phthalic aci;mono(ethylhexyl) phthalate;Monoethylhexyl
SMILES: O(C(C1=C([H])C([H])=C([H])C([H])=C1C(=O)O[H])=O)C([H])([H])C([H])(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]
Formula: C16H22O4
M.Wt: 278.3435
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: MEHP (Phthalic acid mono-2-ethylexyl ester) is a competitive inhibitor of CYP2C9 with IC50 of 6.37 μM.
References: [1]. Bai J, et al. Mono-2-ethylhexyl phthalate induces the expression of genes involved in fatty acid synthesis in HepG2 cells. Environ Toxicol Pharmacol. 2019 Jul;69:104-111. [2]. Chauvigné F, et al. Mono-(2-ethylhexyl) phthalate directly alters the expression of Leydig cell genes and CYP17 lyase activity in cultured rat fetal testis. PLoS One. 2011;6(11):e27172.
MSDS
Cat. No. Product name Field of application
DC72892 MEHP MEHP (Phthalic acid mono-2-ethylexyl ester) is a competitive inhibitor of CYP2C9 with IC50 of 6.37 μM.
DC70373 DX314 DX314 is a potent, specific CYP26B1 inhibitor with IC50 of 108 nM, >15-fold selectivity over CYP26A1.DX314 potentiates all-trans-RA (atRA) gene expression effects in healthy and diseased reconstructed human epidermis (RHE).DX314 potentiates the effects of atRA on the expression and localization of keratin 10 (KRT10), protects barrier function in RHE.DX314 reduces comedonal number, induces epidermal thickening, and increases comedonal profile, while having no effect on transepidermal water loss (TEWL) in treated rhino mice.
DC70372 DX308 DX-308 is a potent, selective dual CYP26A1/B1 inhibitor and retinoic acid metabolism blocking agent.DX308 does not interact with off‐target nuclear receptors or CYP450s, is not genotoxic, and is stable in skin, despite vigorous hepatic metabolism.Topical DX308 induces comedolysis and epidermal thickening without apparent adverse effects in vivo.DX308 shows potent modulation of retinoid‐responsive genes by DX308 in both healthy and keratinization disorder keratinocytes (KCs).DX 308 may present an improved therapeutic alternative for the treatment of keratinization disorders and other retinoid‐responsive skin ailments.
DC50205 Abiraterone decanoate Abiraterone decanoate is a potent Abiraterone prodrug. Abiraterone decanoate provide a controlled release of Abiraterone and long-acting CYP17 inhibition with intramuscular (IM) delivery.
DC11329 Fadrozole (hydrochloride) Fadrozole is a non-steroidal aromatase inhibitor (IC50s = 5 and 1.4 nM for human placental and rat ovarian microsomal aromatase, respectively).
X